The latest biopharma awards press releases and news
NEWSROOM

IMAPAC CELEBRATES THE SUCCESS OF the Biopharma R&D and Clinical Trials Awards (BRCTA) 2023

Singapore, 7 April 2023 – IMAPAC, a leading event organizer in the Biopharma industry, is proud to announce the Biopharma R&D and Clinical Trials Awards (BRCTA) 2023. The BRCTA seeks to recognize exceptional Asian clinical trials leaders, organizations, and technologies over the past year. The awards ceremony will be held on March 15th, 2023, in conjunction with Clinical Trial Festival Asia at the Sands Expo & Convention Centre in Marina Bay Sands, Singapore.
Asia is home to thriving research facilities, clinical research institutes, and is the world’s choice for clinical trials, supporting complex materials supply chains. Therefore, the Biopharma R&D and Clinical Trials Awards applaud outstanding achievements by top clinical trials leaders in the industry, recognizing extraordinary leaders and trend-setters of today and inspiring innovators of tomorrow.
IMAPAC has called for nominations from the IMAPAC biologics community for different biologics award categories. All entries and nominations were considered and submitted to the judging panel and market research team from IMAPAC. Based on the number of nominations and assessment, the top 5 entries under each category were shortlisted. From the top 5 entries, the award winner will be determined by 100% voting results from the public or bioprocessing community.
The BRCTA 2023 Awards ceremony offers an excellent opportunity to recognize the hard work and dedication of clinical trials professionals and organizations involved in biopharmaceutical development and/or manufacturing. Therefore, we encourage all organizations that have a notable presence in APAC and have displayed significant developments in the past few years to apply.
The BRCTA 2023 Awards have various categories, including Excellence Awards, Individual Awards, and Team Awards. These awards aim to recognize the best of the best, with categories such as Best Vaccine CRO of the year, Excellence in Clinical Trial Diversity and Inclusion, Clinical Operations Director of the Year, and Commercialisation and Market Access Team of the Year, among others.
IMAPAC has been serving the Biopharma industry for the past 12 years. We pride ourselves on organizing conferences in a revolutionizing industry and providing new opportunities for those who participate. We are committed to recognizing the efforts and hard work of clinical trials professionals and organizations and the role they play in shaping the future of the Biopharma industry.
For more information on the Biopharma R&D and Clinical Trials Awards (BRCTA) 2023, visit https://biopharmaawards.imapac.com/biopharma-rd-and-clinical-trials-awards-brcta-apac-2023/
About IMAPAC
IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.
RELATED CONTENT
The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) 2023 APAC recognized outstanding achievements in biologistics across Asia at their 2023 ceremony, held alongside the 7th BioLogistics World Asia event. The awards celebrate exceptional personnel, organizations, and technologies in the industry and aim to inspire future innovators.
The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) 2023 APAC recognized outstanding achievements in biologistics across Asia at their 2023 ceremony, held alongside the 7th BioLogistics World Asia event. The awards celebrate exceptional personnel, organizations, and technologies in the industry and aim to inspire future innovators.
IMAPAC has successfully held the Asia-Pacific Bioprocessing Excellence Awards 2023, recognizing outstanding achievements and contributions in bioprocessing. The awards ceremony attracted over 80 participants from more than 40 biopharmaceutical companies across the Asia-Pacific region, with 53 categories such as Best Biomanufacturing Team and Best Emerging Biotech Company.
WuXi Biologics has won two awards at the 2023 APAC Bioprocessing Excellence Awards (ABEA) ceremony: “Best Contract Development and Manufacturing Organization Award” and “Bioprocessing Excellence in Greater China Region Award.” This is the sixth time the company has been recognized by the ABEA. WuXi Biologics supported its clients in obtaining 123 Investigational New Drug approvals in 2022 and currently supports 17 commercial biologics and vaccines.